News Search Results
Sep 23, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers - JSPR
[Click here for information about joining the class action] Jasper, a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria ("CSU"), Chronic Inducible
More news about: Pomerantz LLP
Sep 23, 2025, 09:09 ET Rise Therapeutics Secures New Funding to Advance First-in-Class R-2487 Oral Immune Biomodulator into Sjogren's Disease Clinical Testing
Md., Sept. 23, 2025 /PRNewswire/ -- Rise Therapeutics, a clinical-stage biotechnology company developing a novel class of oral targeted immunotherapies, today announced it will be initiating clinical evaluation of R-2487 in SjD.
More news about: Rise Therapeutics
Sep 23, 2025, 09:00 ET Prellis Biologics Enters Multi-Target Drug Discovery & Development Collaboration with Lilly to Advance Human Antibody Therapeutics
Prellis Biologics, Inc., a biotechnology company innovating human antibody discovery through organoid & artificial intelligence enabled technology, announced a multi-target drug discovery
More news about: Prellis Biologics
Sep 23, 2025, 09:00 ET Noul Secures FDA Registration for Cervical Cancer Diagnostic Cartridge
solutions, and realize those possibilities. Noul has commercialized the world's first AI-powered diagnostic lab, miLab™, through convergence of AI, biotechnology, and compact robotics. The miLab™ Platform is the only solution that fully automates the microscopic diagnostic process—from sample preparation
More news about: Noul
Sep 23, 2025, 08:49 ET Ventoux Biosciences Secures U.S. Patent for Novel Therapy Targeting Dupuytren's Disease and Immune-Fibrotic Disorders
SAN DIEGO, Sept. 23, 2025 /PRNewswire/ -- Ventoux Biosciences, a biotechnology company developing disease-modifying therapies for fibrotic conditions, today announced the issuance of a U.S. patent covering methods for treating
More news about: Ventoux Biosciences
Sep 23, 2025, 08:48 ET World's First Computer-connected Lab Grown Human Bioprinted Skin: CTISKIN™ by CTIBIOTECH™ Sweeps Awards at IFSCC 2025 Congress with Groundbreaking Bioprinted Skin Technology
the broader implications of this innovation: "These awards underscore CTIBIOTECH's commitment to pushing the boundaries of what's possible in biotechnology. It means faster time to market for novel products, reduced development costs, and ultimately, better and safer products for consumers worldwide.
More news about: CTIBIOTECH
Sep 23, 2025, 08:47 ET Gallant Achieves FDA "Technical Section Complete" for Reasonable Expectation of Effectiveness, Advancing First Ready-to-Use Stem Cell Therapy
Gallant, an animal health biotechnology company pioneering ready-to-use stem cell therapies for pets, today announced a key regulatory milestone. The U.S. Food and Drug Administration
More news about: Gallant
Sep 23, 2025, 08:30 ET Cracking Cancer's Code: How AI and RWE are Driving Trials Forward, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 23, 2025, 08:30 ET Advancing Obesity Clinical Development: Emerging Strategies for Next‑Gen Trials, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 23, 2025, 08:30 ET HighVista Strategies Completes Innovative Venture Capital Transaction in the Secondary Market
span private markets, including private credit, lower middle market private equity, and early-stage venture capital; public markets, including biotechnology equities and hedged public markets strategies; as well as multi-strategy alternatives. Media ContactProsek Partners
More news about: HighVista Strategies LLC
Sep 23, 2025, 08:09 ET Santé Ventures Announces Promotion of Michael Gutbrod, PhD to Principal and Addition of Alana Horowitz, PhD as Senior Associate
Promotion and team expansion highlight continued momentum for the firm and reinforce support for breakthrough innovations in biotechnology AUSTIN, Texas, Sept.
More news about: Santé Ventures
Sep 23, 2025, 08:00 ET TegMine Therapeutics Enters Collaboration with Boehringer Ingelheim to Advance Novel 2-Factor Antibody System for Cancer
FRANCISCO, Sept. 23, 2025 /PRNewswire/ -- TegMine Therapeutics, Inc., ("TegMine"), a biotechnology company focused on redefining precision oncology by targeting the glycoproteins that drive cancer, today announced a strategic research and development
More news about: TegMine Therapeutics
Sep 23, 2025, 07:59 ET MLAB Biosciences Expands Scientific Advisory Board with Appointments of Peter Kang and Kathryn Wagner, Deepening Scientific Expertise in Neuromuscular Medicine
NEEDHAM, Mass., Sept. 23, 2025 /PRNewswire/ -- MLAB Biosciences, a biotechnology company pioneering novel therapies for neuromuscular disease, today announced the appointment of Kathryn R. Wagner,
More news about: MLAB Biosciences
Sep 23, 2025, 07:45 ET HealthTrackRx Appoints Keith Koford as Chief Legal Officer
Technology, and a BS in Molecular Biology from Auburn University. He also earned graduate credits toward an MS in Biotechnology at Johns Hopkins University. "As for my next chapter, it is something about which I am incredibly excited," said
More news about: HealthTrackRx
Sep 23, 2025, 07:30 ET Soligenix Announces Appointment of Former White House Economic Adviser Tomas J. Philipson, PhD as Strategic Advisor
procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will
More news about: SOLIGENIX, INC.
Sep 23, 2025, 07:00 ET Triveni Doses First Subject in Global Phase 2 Proof of Concept Study of TRIV-509 in Atopic Dermatitis, Presents Translational Data at 2025 EADV Congress Demonstrating Novel Biology in Patient Samples
Sept. 23, 2025 /PRNewswire/ -- Triveni Bio, Inc., a biotechnology company focused on developing innovative antibody treatments for inflammation and immunology (I&I) disorders, today announced the dosing of
More news about: Triveni Bio
Sep 23, 2025, 06:00 ET Bridge to Life Announces the Appointment of Life Sciences Industry Veteran Brian Lenz as Chief Financial Officer
Officer and General Manager of its subsidiary ADMA BioCenters. Previous to ADMA he was the CFO and COO at CorMedix, and prior, served as CFO in other biotechnology companies. Mr. Lenz began his professional journey in audit with KPMG. Mr. Lenz is a licensed CPA, earned his bachelor's degree from Rider
More news about: Bridge to Life, Ltd.
Sep 23, 2025, 03:46 ET AI in Oncology For Analytical Solutions Market Size & Share to Surpass $8.86 Billion by 2035, Growing at a CAGR 21% | Vantage Market Research
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Sep 23, 2025, 00:01 ET Flagship Pioneering Appoints Yvonne Hao as Chief Operating Officer and General Partner
Sana Biotechnology,
More news about: Flagship Pioneering
Sep 22, 2025, 13:23 ET Rubin Rudman Partners Ariadna Caulfield and Marlee S. Cowan Elected to Massachusetts Bar Association Leadership Roles
Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin Rudman
Sep 22, 2025, 11:31 ET Hydrogen Fuel Cell (HFC) Market Size & Share to Surpass $42.3 Billion by 2035, Growing at a CAGR 20% | Powering the Future of Clean Energy, Transportation, and Industrial Transformation
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Sep 22, 2025, 11:30 ET Lab Automation Market is Projected To Reach US$8.71 Billion By 2031 at CAGR of 6.3% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.
More news about: The Insight Partners
Sep 22, 2025, 11:16 ET RNA-based Therapies Market to Reach USD 213.54 Billion by 2033, Driven by Rare Diseases, Oncology, and Advances in RNA Technologies | DataM Intelligence
and is projected to grow at double-digit rates. Key growth factors include: Increasing government investments in advanced biotechnology.Partnerships between Japanese firms and global biopharma for RNAi and ASO therapies.PMDA's regulatory flexibility, supporting
More news about: DataM Intelligence 4 Market Research LLP
Sep 22, 2025, 11:14 ET Global Office Sleep Pod Market Expected to Surge to USD 550 Million by 2033, Growing at a Robust CAGR of 12.5% from 2026 to 2033 - Market Research Intellect
Analytics Tools, Patent Valuation Software, Patent Management Systems, Patent Portfolio Management Tools), By End-User Industries (Pharmaceuticals, Biotechnology, Information Technology, Automotive, Manufacturing), By Deployment Type (Cloud-Based, On-Premises, Hybrid), Regional Analysis, And Forecast
More news about: Market Research Intellect
Sep 22, 2025, 11:01 ET Electronic Signature Software Market Is Projected To Reach US$35.71 Billion By 2031 At CAGR Of 34.6% | Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners